Which of the following is not used for the treatment of insulin induced hypoglycemia?
**Core Concept**
The management of insulin-induced hypoglycemia involves administering a rapid source of glucose to elevate blood glucose levels. Treatment options include glucose-containing solutions, glucagon, and other medications that stimulate glucose release or inhibit glucose uptake.
**Why the Correct Answer is Right**
Glucagon is a hormone produced by the pancreas that stimulates the liver to release stored glucose (glycogen) into the bloodstream. It is a crucial treatment for hypoglycemia, especially in cases where the patient is unable to take oral glucose. Glucagon works by activating the enzyme glycogen phosphorylase, which breaks down glycogen into glucose, which is then released into the bloodstream.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it is not specified, but in general, oral glucose or glucagon would be used to treat hypoglycemia, not this option.
**Option B:** This option is incorrect as it is not typically used for the treatment of insulin-induced hypoglycemia. Glucagon is the preferred treatment.
**Option C:** This option is incorrect as it is not typically used for the treatment of insulin-induced hypoglycemia. Glucagon is the preferred treatment.
**Clinical Pearl / High-Yield Fact**
In the event of severe hypoglycemia, especially in patients who are unable to take oral glucose, glucagon is a lifesaving treatment that should be administered promptly. It is essential to have a glucagon emergency kit available in the hospital or clinic setting.
**Correct Answer: B. This option is incorrect as it is not typically used for the treatment of insulin-induced hypoglycemia. Glucagon is the preferred treatment.